Unlock measurable value at every stage of the clinical development and commercialization journey.
Discover our award-winning AI, digital innovation, and healthcare marketing initiatives.
AI-powered insights grounded in decades of life sciences experience for smarter pipeline decisions and strategies.
AssetNav, part of Navigator AI™, helps life sciences organizations make more informed portfolio and business development decisions by identifying the assets and opportunities with the strongest potential. Combining best-in-class data sources, AI-enabled intelligence, and decades of commercialization expertise, AssetNav supports our consultants in assessing commercial potential, strategic fit, and clinical attractiveness. Enhanced AI-driven analog ID algorithms enable rapid evaluation of potential market share and uptake across different product profiles. Together, these insights provide a clearer view of portfolio opportunities, helping clients prioritize the right investments faster and with greater confidence, advancing Intelligent Commercialization™ and supporting stronger portfolio outcomes.
Data and insights are central to what we do. With AssetNav, a product pipeline tool, in our Navigator AI™ suite, our teams can help you to quickly identify and prioritize assets, to power smarter decision-making.
Smart decisions: Enables real-time strategic decision making, with the ability to rapidly refresh data in the future
Visual insights: Summarized view of data in strategic charts (market, disease, biomarker, asset, trial-level, etc.)
Comparative scores: Comprehensive scoring across various scientific, regulatory and commercial attributes
AI & ML models: Trained machine learning and artificial intelligence models add ability to predict and interpret key insights from trial data such as anticipated time to market, patient-type categorization, expected line of therapy, and other results
Market share & uptake: Rapidly benchmark potential market share and uptake using relevant market analogs and proprietary market data
Deeper insights. Faster: Real time access to pre-structured / merged data from 10+ sources providing instant access to deeper insights, at the touch of a button
Instant filtering: Ability to instantly distil and restructure information or present multiple assets on a prioritized basis
Natural-language exploration: Rapidly test different product assumptions to understand which attributes may have greater or lesser impact on commercial potential
We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.
Using Inizio’s proprietary AssetNav tool, we provided information updated in real-time and delivered efficiencies by speeding up the project timeline.
Jo Ann helps clients use data, analytics, and AI to solve complex challenges and drive sustainable growth. She defines strategy, value cases, capability readiness, and responsible AI needs to build POCs and MVPs and support implementation at scale.
John helps clients build clinical development and go-to-market strategies across therapy areas. He guides decisions on target profiles, clinical paths, competitive positioning, and opportunity sizing to support early-stage asset prioritization.
As President of Putnam, Matt leads a team focused on strategic acuity and patient impact. He has partnered with global biopharma across therapeutic areas from pipeline shaping to launch, applying structured thinking and objective analysis to drive results.
Mariah translates insights from primary and secondary research into clear strategic guidance across neurology, rare diseases, oncology, and vaccines. She brings deep expertise in qualitative and quantitative methods and actionable insight development.
We connect data, technology, and AI through an expert-driven, unified framework that enables Intelligent Commercialization™ across every stage of the health and life sciences journey. Our platforms, products, and solutions work together by design to deliver scalable, data-driven impact.
Let us help you find your way.
